Literature DB >> 24262688

Chronic spontaneous urticaria: etiology and pathogenesis.

Sarbjit S Saini1.   

Abstract

Urticaria affects individuals of all ages and is commonplace. Nearly 1 in 5 individuals will experience an episode of urticaria in their lifetime, while the chronic form of disease has an estimated annual prevalence of approximately 1% of the population. Given the similarity of chronic urticaria symptoms to those seen in patients suffering an allergic reaction, the condition often leads to a search for an external cause. In most cases, no external trigger factor is identified. At present several theories of pathogenesis exist, none of which is firmly established.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basophils; Chronic urticaria; Mast cells

Mesh:

Year:  2013        PMID: 24262688     DOI: 10.1016/j.iac.2013.09.012

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  33 in total

Review 1.  Placebo effects on itch: a meta-analysis of clinical trials of patients with dermatological conditions.

Authors:  Antoinette I M van Laarhoven; Ineke M van der Sman-Mauriks; A Rogier T Donders; Mathilde C Pronk; Peter C M van de Kerkhof; Andrea W M Evers
Journal:  J Invest Dermatol       Date:  2014-12-01       Impact factor: 8.551

2.  Management of chronic spontaneous urticaria in the elderly.

Authors:  Maria Teresa Ventura; Nicoletta Cassano; Paolo Romita; Michelangelo Vestita; Caterina Foti; Gino Antonio Vena
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

Review 3.  Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Authors:  A P Kaplan; A M Giménez-Arnau; S S Saini
Journal:  Allergy       Date:  2017-01-04       Impact factor: 13.146

Review 4.  Chronic Spontaneous Urticaria: The Devil's Itch.

Authors:  Sarbjit S Saini; Allen P Kaplan
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jul - Aug

5.  Application value of laboratory indexes in the differential diagnosis of Henoch-Schoenlein purpura.

Authors:  W-X Shao; Q Ye; X-J Wang
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

6.  The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.

Authors:  Kirti J Johal; Kristin L Chichester; Eric T Oliver; Kelly C Devine; Anja P Bieneman; John T Schroeder; Donald W MacGlashan; Sarbjit S Saini
Journal:  J Allergy Clin Immunol       Date:  2021-03-10       Impact factor: 14.290

7.  Suppression of basophil FcɛRI activation by serum from active chronic idiopathic/spontaneous urticaria (CIU/CSU) subjects.

Authors:  Patricia M Sterba; Robert G Hamilton; Sarbjit S Saini
Journal:  J Invest Dermatol       Date:  2015-02-03       Impact factor: 8.551

8.  Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria.

Authors:  Michael S Broder; Karina Raimundo; Evgeniya Antonova; Eunice Chang
Journal:  Am J Clin Dermatol       Date:  2015-08       Impact factor: 7.403

9.  ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria.

Authors:  Karsten Weller; Marcus Maurer; Clive Grattan; Alla Nakonechna; Mohamed Abuzakouk; Frédéric Bérard; Gordon Sussman; Ana M Giménez-Arnau; Javier Ortiz de Frutos; André Knulst; G Walter Canonica; Kelly Hollis; Doreen McBride; Maria-Magdalena Balp
Journal:  Clin Transl Allergy       Date:  2015-08-17       Impact factor: 5.871

10.  Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk.

Authors:  Massimo Cugno; Alberto Tedeschi; Alessandro Borghi; Paolo Bucciarelli; Riccardo Asero; Luigia Venegoni; Samantha Griffini; Elena Grovetti; Emilio Berti; Angelo Valerio Marzano
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.